| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.094 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |